In another study that aimed to investigate somatic mutations in tumors from Taiwanese young breast cancer patients, Midha et al. reported a high prevalence of somatic mutations in TP53 (40%) (Midha et al., 2020). This evidence concerns the gene TP53 and breast carcinoma.